Abstract OT1-15-01: SGNTUC-019: Phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations: <i>HER2-</i>mutated breast cancer cohort (ongoing clinical trial)

Authors: Alicia Okines, Paula R. Pohlmann, Jorge Ramos, Luke Walker, Erika Hamilton

Published: 2022-03-08

DOI: 10.1158/1538-7445.sabcs21-ot1-15-01

Source: Full article